Τόμος 22 (2008) – Τεύχος 2 – Άρθρο 82 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 22 (2008) – Issue 2 – Article 82 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Quality of perioperative chemoprophylaxis in neurosurgery: preliminary results of ASPPOC in South Europe
Authors P. Papaioannidou1, K. Nanassis2, A. Sabo3, V. Vlahovic-Palcevski4, L. Pejakov5, O. Horvat3, M. Jakovljevic6, P. Selviaridis7, G.-M. Benoni8, L. Cuzzolin8, Z. Tomic3, S. Jankovicand G. Velo8

1. Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Greece

2. 2nd Department of Neurosurgery, Medical School, Aristotle University of Thessaloniki, Greece

3. Department of Pharmacology, Toxicology and Clinical Pharmacology, Medical School, University of Novi Sad, Serbia

4. Unit of Clinical Pharmacology, University Hospital Rijeka, Croatia

5. Department of Anesthesia and Internal Care Unit, Clinical Center Podgorica, Montenegro

6. Center of Clinical and Experimental Pharmacology, Medical School, University of Kragujevac, Serbia

7. 1st Department of Neurosurgery, Medical School, Aristotle University of Thessaloniki, Greece

8. Department of Pharmacology, Faculty of Medicine and Public Health, University of Verona, Italy

Citation Papaioannidou, P., Nanassis, K., Sabo, A., Vlahovic-Palcevski, V., Pejakov, L. et al.: Quality of perioperative chemoprophylaxis in general surgery: preliminary results of ASPPOC in South Europe, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 276-278 (2008)
Publication Date 23-25 May 2008
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Antibiotics, perioperative chemoprophylaxis, postoperative infections, neurosurgery.
Other Terms Review article
Summary Aim: The ASPOC Project (ASPPOC, Antibiotic Surveillance Project on Perioperative Chemoprophylaxis) is a multicentric study carried out in European countries, aiming at improving the quality and establishing a successful and evidence-based perioperative chemoprophylaxis. The aim of this study, which is part of ASPPOC, was to check conformance to the guidelines for perioperative chemoprophylaxis in Neurosurgery, and to trace out changes that must be made in South European countries to improve its quality.

Methods: 5 European countries participated in the study: Greece, Italy, Serbia, Croatia and Montenegro. Conformance to the recommended guidelines and quality of perioperative chemoprophylaxis were checked by use of the same questionnaire in each country. The following criteria of quality in chemoprophylaxis were checked: 1) application of chemoprophylaxis, 2) duration and time of initiation of chemoprophylaxis and 3) the kind of antibiotics used.

Results: A different practice on application and quality of perioperative chemoprophylaxis was observed in each country, and even among different Neurosurgery Departments of the same country. Chemoprophylaxis was usually initiated during pre-induction to anesthesia but its duration exceeded the maximum recommended time of 24 hours in many cases in all countries except Italy. Discrepancies in the kind of preferred antibiotics was observed in all countries, with use of 3rd generation cephalosporins (ATC code J01DD) – and even 4th generation cephalosporins (ATC code J01DE) in Croatia. Aminoglycosides (ATC code J01GB) were also used in Italy, Serbia and Montenegro.

Conclusions: The quality of perioperative chemoprophylaxis was not satisfactory, and serious inconsistencies to the recommended guidelines were observed in many cases. Dynamic changes are required in order to improve the quality and establish a successful and evidence-based perioperative chemoprophylaxis in neurosurgery.

References 1. Network for Surveillance of the Rational and Evidence-Based Use of Antibiotics. Antibiotic Surveillance Project on Perioperative Chemoprophylaxis (ASPPOC).

antibiosurv.web.auth.gr

2. World Health Organization. WHO Recommended Surveillance Standards 1999, WHO/CDS/CSR/ISR/99.2

3. World Health Organization. WHO Surveillance Standards for Antimicrobial Resistance 2002, WHO/CDS/CSR/DRS/2001.5

4. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance 2001, WHO/CDS/CSR/DRS/2001.2

5. Papaioannidou P., Nanassis K., Vlahovic-Palcevski V., Tsitsopoulos Ph.: Chemoprophylaxis in Neurosurgery Departments in Croatia and Greece. Rev. Clin. Pharmacol. Pharmacokinet. 20: 289-291 (2006)

6. Papaioannidou P.G., Nanassis K., Stojiljkovic M.P., Loncar-Stojiljkovic D., Tsitsopoulos Ph.: Chemoprophylaxis in Neurosurgery Departments in Denmark and Greece. Αbstracts of the19th European Congress on Surgical Infections p. 91 (2006)

7. Papaioannidou P., Vlahovic-Palcevski V., Nanassis K., Stojiljkovic M.P., Loncar-Stojiljkovic D., Tsitsopoulos Ph.: Peri-operative Chemoprophylaxis in Neurosurgery in Denmark, Croatia and Greece. Bas. Clin. Pharmacol. Toxicol. 101(Suppl. 1): 155 (2007)

8. National Surgical Infection Prevention. Medicare Quality Improvement Project. www.surgicalinfectionprevention.org

9. Cacciola F., Cioffi F., Anichini P., Di Lorenzo N.: Antibiotic prophylaxis in clean neurosurgery. J. Chemother. 13: 119-122 (2001)

10. Barker F.G.: Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery 51: 391-401 (2002)

11. Erman T., Demirhindi H., Gocer A.I., et al.: Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis. Surg. Neurol. 63: 107-113 (2005)

12. Bratzler D.W., Houck, P.M.: Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 189: 395–404 (2005)

13. Antimicrobial prophylaxis in surgery. Med. Lett. Drugs Ther. 43: 92–97 (2001)

14. Ratilal B., Costa J., Sampaio C.: Cochrane Database of Systematic Reviews 2006, Issue 3

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.